This comes amidst UK experiencing a record boom in private healthcare on the back of National Health Service (NHS) waiting lists.
The National Pharmaceutical Pricing Authority (NPPA) on Wednesday justifying its price ceiling indicated that it still left enough room for the stent makers to make a decent margin and the drug price control order (DPCO) has provision for separate prices for superior products – two main concerns raised by the stent manufacturers.
In an interview with CNBC-TV18, Devi Shetty, Chairman of Narayana Hrudayalaya said that dengue is a global problem but India is not doing enough to prevent it.
Devi Shetty, Chairman, Narayana Hrudayalaya is of the view that the intention of the government for imposing this tax is not clear.
For five years, the Shri Mata Vaishno Devi Shrine Board will cover the losses, if any, of the healthcare provider to the tune of Rs 45-50 crore, says Dr Devi Shetty, Chairman of Narayana Hrudayalaya.
Narayana Hrudayalaya was listed at the NSE at Rs 299 per share, up 20 percent from its issue price. It touched intraday high of Rs 345.65, up 38.26 percent on Wednesday. On the BSE, it touched a high of Rs 344.20 per share and traded with volumes of 8,951,359 shares.
Promoted by renowned cardiac surgeon Devi Shetty, the healthcare service major‘s initial public offer (IPO) opened on December 17 and closed on December 21. It has raised Rs 184 crore from 15 anchor investors at Rs 250 per share.
Meanwhile, with a price band between Rs 245-Rs 250, Narayana Hrudayalaya opened on December 17 and closed on December 21. It was subscribed 8.67 times. It has raised Rs 184 crore from 15 anchor investors at Rs 250 per share.
Narayana Hrudayalaya has raised Rs 184 crore from 15 anchor investors, including the Singapore government, at the upper price band
The Rs 613-crore IPO received bids for 51,12,900 shares against the total issue size of 1,71,66,309 shares, data available with the NSE till 1700 hrs showed.
The Rs 613-crore IPO received bids for 12,34,860 shares against the total issue size of 1,71,66,309 shares, data available with NSE till 1700 hours showed.
ICICIdirect.com advises to subscribe stating though it thinks valuation is a tad expensive, it is in line with the recent deals in the healthcare industry. It says that Narayana's calibrated model for establishing and expanding its hospitals has allowed it to achieve a more efficient use of capital than many of its peers.
The Devi Shetty-run hospital company has allotted 73.57 lakh equity shares at Rs 250 per share aggregating to Rs 183.93 crore to anchors investors like Morgan Stanley, Mirae Asset Management, Nomura, Government of Singapore, Reliance AMC, Birla Sun Life, DSP Blackrock, UTI, ICICI Prudential, SBI MF among others.
In an interview to CNBC-TV18, Dr Devi Shetty, founder, Narayana Health, shares his views on the company's upcoming IPO.
Checkout how VST Tillers and Tractors changed the way you look at farming through innovations.
Four years before the phrase ‘stay foolish‘ was made cool by Steve Jobs, thousands of Bangaloreans were already proudly foolish.
Dr Devi Shetty, the 60-year old Padma Bhushan winner shows how to mix business with social responsibility and be very successful.
Four solutions for India's health care sector
Renowned Indian heart surgeon Devi Shetty has struck a deal to build a 2,000-bed healthcare city in the Cayman Islands to target American patients and insurers searching for deeply discounted medical care.
After receiving severe criticism from the industry for central excise duty, the Finance Ministry may give it a second thought. The government may partially roll back central excise duty on some items, reports CNBC-TV18 quoting sources.